MFI highlights that wait for national strategy on affordable biosmiliars goes on

Medicines for Ireland (MFI), the organisation which represents over 60% of medicines supplied to the HSE has called for the Government to stop dragging its feet on biosimilars and to create a dynamic environment for the supply of cost-effective medicines for patients.

MFI has highlighted that it is now more than two years since Minister for Health, Simon Harris TD, first announced Government plans to establish a National Biosimilars Policy for Ireland.